Sigilon Therapeutics

2 followers

‌

Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.

Industries

Headquarters

Cambridge, United States

Employees

Links

Org chart

Rogerio Vivaldi

President & CEO

Rogerio Vivaldi

Collapse

Chief Technical Operations Officer

Philip Ashton-Rickardt

Chief Scientific Officer

Olivia G. Kelly

VP, Head, Islet Cell Therapy Research

VP & Head, Immune Mediated Diseases

VP, Finance & Controller

VP Of Finance & Controller

Co-founder

Corporate Director

Teams

Leadership Team

9 members

Administration and Executive Management

11 members

Scientific and Research Team

11 members

Advisors Team

5 members

Finance and Quality Team

4 members

Offices

This company has no offices yet

Similar companies

Stemline Therapeutics

3 followers

Generation Bio

2 followers

Celldex Therapeutics

2 followers

Adicet Bio

1 follower

Vividion Therapeutics

1 follower

Zymo Research

1 follower

Mission Bio

4 followers

Thermo Fisher Scientific

173 followers

Genentech

159 followers

Biogen

119 followers

Mercedes Scientific

4 followers

Explore companies